In this week's video, Dr. Brian Durie discusses selinexor, a novel, orally administered drug that is currently ongoing clinical trials.

Bottom Line:

Selinexor is a promising new type of drug that can make a difference for myeloma patients.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.